Ruiquan Liu

Ruiquan Liu

Auto-generated profile, based on publicly available information

Ruiquan Liu

Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
RLRuiquan Liu
Ruiquan Liu
ZDZhu Deng
Zhu Deng
LZLi Zhang
Li Zhang
YLYin Liu
Yin Liu
ZWZheng Wang
Zheng Wang
YYYanbing Yu
Yanbing Yu
Purpose: Microvascular decompression (MVD) and MVD combined with partial sensory rhizotomy (PSR) are effective surgical treatments for idiopathic trigeminal neuralgia (TN). The aim of this study was to compare the long-term outcomes of both MVD and MVD+PSR for the treatment of TN and to identify the factors that may influence the long-term outcomes after MVD or MVD+PSR. Patients and Methods: From March 2009 to December 2017, 99 patients with idiopathic TN who underwent MVD or MVD+PSR in our hospital (40 MVD, 59 MVD+PSR) were included in the study. The indications for MVD+PSR were as follows: vessels only contacted the nerve root, absence of arterial conflict, or failing to completely decompress from the arteries or veins. All patients were treated by one neurosurgeon and were followed up for at least 1 year. The outcomes were assessed with the Barrow Neurological Institute (BNI) Pain Intensity Scale. Results: The average follow-up duration was 63.0 months (range, 13.2– 118.8 months). Patients in the MVD group were younger than those in the MVD+PSR group (55.1 years and 60.5 years, respectively, P=0.012). A total of 62.5% of the patients in the MVD group and 69.5% of the patients in the MVD+PSR group had favorable long-term outcomes. The Kaplan-Meier survival analysis showed no significant difference in long-term outcomes between the two groups (P=0.202). No factors were associated with long-term outcomes after MVD. For MVD+PSR, a long duration of the disease (odds ratio (OR) 6.967, P=0.016) was associated with unfavorable long-term outcomes, whereas pure arterial compression (OR 0.131, P=0.013) was associated with favorable long-term outcomes. Conclusion: For patients who are not suitable to undergo pure MVD, MVD+PSR can be used as an effective alternative. For MVD+PSR, patients with a long duration of symptoms may have poor long-term outcomes, while patients with pure arterial compression may have favorable long-term outcomes.

16 December 2019 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
RLRuiquan Liu
Ruiquan Liu
YLYi Long
Yi Long
LLLiu Liu
Liu Liu
XZXian Zhao
Xian Zhao

14 November 2025 in Science Advances
Verified
Journal Article
Open access
YLYi Long
Yi Long
KLKaini Liang
Kaini Liang
YNYudi Niu
Yudi Niu
RWRui Wang
Rui Wang
RLRuiquan Liu
Ruiquan Liu
YDYanan Du
Yanan Du
Cirrhosis-associated portal hypertension drives vascular injury, yet the pathogenesis mediated by abnormal hydrostatic pressure (HP) remains unclear due to the absence of in vitro models replicating the cirrhotic perivascular mechanical microenvironment. Here, we developed 2D static and 3D dynamic “hepatic hypertension on-a-chip” (HH chip) systems replicating cirrhotic hemodynamics and matrix properties. The HH chip realized integration and decoupled regulation of HP, shear stress, and matrix stiffness. Liver sinusoidal endothelial cells (LSECs) exhibited HP-induced damage exclusively on stiff matrices, recapitulating cirrhotic degeneration phenotypes and genotypes. Using the HH chip, we identified GPR116 as the key HP mechanosensor in LSECs and delineated its downstream mechanotransduction pathway driving cellular injury. Genetic silencing of GPR116 protected endothelial cells from HP-induced damage both in vitro and in cirrhotic murine models. Cell- and gene-based therapies targeting GPR116 significantly attenuated cirrhosis progression. The HH chip can accelerate pathological investigation, target identification, and therapeutic development for hypertension-associated diseases.

1 October 2019 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
ZDZhu Deng
Zhu Deng
RLRuiquan Liu
Ruiquan Liu
YLYin Liu
Yin Liu
ZWZheng Wang
Zheng Wang
YYYanbing Yu
Yanbing Yu
LZLi Zhang
Li Zhang
Objective: Microvascular decompression (MVD) combined with partial sensory rhizotomy (PSR) with the retrosigmoid approach has become the most effective surgical treatment for trigeminal neuralgia (TN). There is variability in the pain relief processes observed in postoperative patients. The purpose of this study was to investigate delayed relief (DR) and its predictors after MVD and/or PSR for the treatment of TN and study the long-term effects associated with DR. Methods: Patients with primary TN who underwent MVD and/or PSR by the same surgeon at the China-Japan Friendship Hospital from March 2009 to December 2017 were included in the study, and all patients were followed for at least 1 year after the operation. DR was defined as follows: no changes in the Barrow Neurological Institute (BNI) score on the third day after surgery and a BNI score of I-II in the absence of any medication after a period of pain. Preoperative, intraoperative and postoperative differences were compared between the DR and non-DR groups, and the relationships between the various factors and DR was analyzed. Results: A total of 105 patients, including 20 patients with DR (19%), 78 patients with non-DR (74%), and 7 patients without relief, were included in this study. The follow-up period ranged from 13 months to 118 months (average, 5.39 years/65 months). The duration of postoperative pain in the DR group was 3–365 days, with an average of 108 days. Statistical analysis found that no factor predicted the occurrence of DR, and the occurrence of postoperative DR did not affect the long-term effects observed in patients. Conclusion: DR did not affect the long-term effects after MVD and/or PSR. Therefore, it is recommended that patients should be monitored for approximately 3 months after MVD and/or PSR and then evaluated for surgical effects. No reoperations should be performed immediately.

15 March 2022 in Laryngoscope Investigative Otolaryngology
Verified
Journal Article
Open access
RLRuiquan Liu
Ruiquan Liu
JCJianguo Chen
Jianguo Chen
LJLitao Jia
Litao Jia
BPBo Pan
Bo Pan
HJHaiyue Jiang
Haiyue Jiang
Auricular arteriovenous malformations (AVMs) can cause a variety of symptoms that seriously impact the patient's appearance, life, and mental well‐being. Surgery is the primary management method for auricular AVMs, but there is no consensus on how to surgically manage auricular AVMs. In this article, we document a comprehensive review of the characteristics, classification, and surgical interventions to treat auricular AVMs.

8 April 2020 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
RLRuiquan Liu
Ruiquan Liu
XZXian Zhao
Xian Zhao